Successfully reported this slideshow.

Global pharmaceutical industry outlook survey 2011

883 views

Published on

The opinions and forward looking statements of 764 industry executives have been captured in our in-depth survey, of which 41% represent Director and C-level respondents The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations The geographical scope of the research is global – drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East This report covers data and analysis on buyer expenditure, procurement and industry developments Key topics covered include packaging buyer expenditure activity, procurement behaviors and strategies, threats and opportunities for the pharmaceutical industry, economic outlook and business confidence.

Published in: Business, News & Politics
  • Be the first to comment

  • Be the first to like this

Global pharmaceutical industry outlook survey 2011

  1. 1. Global Pharmaceutical Industry Outlook Survey 2011–2012: Industry Dynamics,Market Trends and Opportunities, Buyer Spend and Procurement StrategiesReport SummaryThis report is the result of an extensive survey drawn from ICD Research’s exclusive panelof leading pharmaceutical industry executives. It analyzes how pharmaceutical companies’procurement expenditure, business strategies and practices are set to change in 2011–2012. This report gives you access to the category-level spending outlooks, budgets,supplier selection criteria, business challenges and investment opportunities of leadingpurchase decision makers. The report also identifies future growth of buyers and suppliers,M&A and e-procurement. This report not only grants access to the opinions and strategies ofbusiness decision makers and competitors, but also examines their actions surroundingbusiness priorities. The report also provides access to information categorized by region,company type and sizes.ScopeThe opinions and forward looking statements of 764 industry executives have been capturedin our in-depth survey, of which 41% represent Director and C-level respondents Theresearch is based on primary survey research conducted by ICD Research accessing its B2Bpanels comprised of senior purchase decision makers and leading supplier organizations Thegeographical scope of the research is global – drawing on the activity and expectations ofleading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle EastThis report covers data and analysis on buyer expenditure, procurement and industrydevelopments Key topics covered include packaging buyer expenditure activity,procurement behaviors and strategies, threats and opportunities for the pharmaceuticalindustry, economic outlook and business confidence.Buy Now: Pharmaceutical IndustryBrowse All: Latest Market Research ReportsIn the report buyers identify what suppliers need to do to maintain their business and thekey actions being taken by industry players to overcome the leading business threatsThereport examines current practices and provides future expectations over the next 12-24months The report provides qualitative analysis of the key industry threats andopportunities and contains full survey resultsReasons To BuyDrive revenues by understanding future product investment areas and growth regionsFormulate effective sales and marketing strategies by identifying how buyer budgets arechanging and direction of spend in the futureBetter promote your business by aligning your capabilities and business practices with yourcustomer’s changing needsSecure stronger customer relationships by understanding the leading business concerns andchanging strategies of industry buyersPredict how the industry will grow, consolidate and where it will stagnate
  2. 2. Uncover the business outlook, key challenges and opportunities identified by suppliers andbuyersKey HighlightsChina, India and Brazil are predicted to be the fastest growing regions among developingcountries for the pharmaceutical industry. An aging population, growth of chronic diseases,expanding healthcare insurance coverage, urbanization and increasing investment in ruralhealthcare services are major drivers for the growth.The majority of the pharmaceutical companies will be increasing procurement spend overthe next 12 months. The average size of the annual procurement budgets of pharmaceuticalmanufacturing companies, CROs and CMOs is US$110 million.Overall, 44% of respondents from pharmaceutical industry buyers agree that in order tomaintain and win their business, suppliers will have to engage in partnerships to optimizeworking capital and reduce costs.TABLE OF CONTENTSLIST OF FIGURES1 Introduction1.1 What is this report about?1.2 Definitions1.3 Methodology1) Online Survey2) Secondary Research3) Data Analysis and Report Writing4) Quality Control1.4 Profile of survey respondents1.4.1 Profile of buyer respondents1.4.2 Profile of supplier respondents2 Executive Summary3 Industry Dynamics3.1 Revenue growth expectations3.1.1 Revenue growth expectations by company type3.1.2 Revenue growth expectations by region3.1.3 Revenue growth expectations by turnover3.1.4 Revenue growth expectations by senior level respondents3.1.5 Revenue growth expectations: cross industry comparisons3.2 Future developments in business structure3.2.1 Future developments by buyers3.2.2 Future developments by suppliers3.3 Merger and acquisition activity predictions3.3.1 Merger and acquisition activity predictions by buyers3.3.2 Merger and acquisition activity predictions by suppliers3.3.3 Merger and acquisition activity predictions by region
  3. 3. 3.3.4 Merger and acquisition activity predictions by company turnover3.3.5 Merger and acquisition activity expectations vs. expansion abroad4 Pharmaceutical Market Growth Outlook4.1 Demand in emerging markets4.1.1 Demand in emerging markets by buyers4.1.2 Demand in emerging markets by suppliers4.1.3 Demand in emerging markets by region4.1.4 Demand in emerging markets by company turnover4.2 Growth expectations in developed countries4.2.1 Growth expectations in developed countries by buyers4.2.2 Growth expectations in developed countries by suppliers4.2.3 Growth expectations in developed countries by region4.2.4 Growth expectations in developed countries by company turnover5 Threats And Opportunities for the Pharmaceutical Industry5.1 Leading business concerns for 2011–20125.1.1 Leading business concerns for the period by company type5.1.2 Leading business concerns by region5.1.3 Leading business concerns by company turnover5.2 Key supplier actions to maintain and win buyer business5.2.1 Actions to maintain and secure buyer business by buyers5.2.2 Actions to maintain and secure buyer business by region5.2.3 Actions to maintain and secure buyer business by turnover5.2.4 Actions to maintain and secure buyer business by procurement budget5.2.5 Actions to maintain and secure buyer business by purchasing decision authority6 Pharmaceutical Industry Buyer Spend Activity6.1 Annual procurement budgets6.1.1 Annual procurement budgets by company type6.1.2 Annual procurement budgets by region6.1.3 Annual procurement budgets by company turnover6.2 Planned change in procurement spend6.2.1 Planned change in procurement spend by buyer type6.2.2 Planned change in procurement spend by region6.2.3 Planned change in procurement spend by company turnover6.2.4 Planned change in expenditure vs. revenue growth optimism6.2.5 Planned change in expenditure vs. cost containment6.2.6 Planned change in procurement spend – cross industry comparisons6.3 Planned change in procurement spend by product and service category6.3.1 Planned change in procurement spend by product and service category – region6.3.2 Planned change in procurement spend by product and service category – companyturnover6.4 Variations in regional supplier prices6.4.1 Variations in regional supplier prices by company type6.4.2 Variations in supplier prices by region6.4.3 Variations in regional supplier prices by company turnover
  4. 4. 7 Procurement Behaviors and Strategies7.1 Critical success factors for supplier selection7.1.1 Critical success factors by company type7.2 Future procurement objectives7.2.1 Future procurement objectives by company type7.2.2 Future procurement objectives by region7.2.3 Future procurement objectives by company turnover7.3 E-procurement7.3.1 E-procurement by company type7.3.2 E-procurement by region7.3.3 E-procurement by company turnover8 Appendix8.1 Full survey results8.2 Methodology8.3 Contact us8.4 About ICD Research8.5 DisclaimerList of TablesTable 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2011Table 2: Buyer Respondents by Job Role (%), 2011Table 3: Buyer Respondents by Company Turnover (%), 2011Table 4: Buyer Respondents by Total Number of Employees in Organizations (%), 2011Table 5: Buyer Respondents by Region (%), 2011Table 6: Supplier Respondents by Job Role (%), 2011Table 7: Supplier Respondents by Company Turnover (%), 2011Table 8: Supplier Respondents by Total Number of Employees in Organizations (%), 2011Table 9: Supplier Respondents by Region (%), 2011Table 10: Revenue Growth Optimism (%), 2009–2011Table 11: Revenue Growth Optimism by Buyers (%), 2009–2011Table 12: Revenue Growth Optimism by Suppliers (%), 2009–2011Table 13: Revenue Growth Optimism by Region (%), 2009–2011Table 14: Revenue Growth Optimism by Turnover (%), 2011Table 15: Revenue Growth Optimism by Senior Level Respondents (%), 2011Table 16: Key Changes In Business Structure in the Pharmaceutical Manufacturer Industry(%), 2011Table 17: Key Changes In Business Structure in the CRO and CMO Industry (%), 2011Table 18: Key Changes In Business Structure in the Drug Manufacturing Supplier Industry(%), 2011Table 19: Merger and Acquisition Expectations Pharmaceutical Manufacturer Industry,2009–2011Table 20: Merger and Acquisition Expectations CRO and CMO Industry, 2009–2011Table 21: Merger and Acquisition Expectations Drug Manufacturing Supplier Industry, 2009–2011Table 22: Merger and Acquisition Expectations by Region, 2011Table 23: Merger and Acquisition Expectations by Company Turnover, 2011
  5. 5. Table 24: Merger and Acquisition Activity Expectations vs. Expand Abroad (%), 2011Table 25: Demand in Emerging Markets by Pharmaceutical Manufacturer (%), 2011Table 26: Demand in Emerging Markets by CRO and CMO Industry (%), 2011Table 27: Demand in Emerging Markets by Drug Manufacturing Supplier (%), 2011Table 28: Growth Expectations in Developed Countries by Pharmaceutical Manufacturer(%), 2011Table 29: Growth Expectations in Developed Countries by CRO and CMO (%), 2011Table 30: Growth Expectations in Developed Countries by Drug Manufacturing Supplier (%),2011Table 31: Leading Business Concerns (%), 2009–2010, 2010–2011,2011–2012Table 32: Leading Business Concerns by Company Type (%), 2011–2012Table 33: Leading Business Concerns by Region (%), 2011–2012Table 34: Leading Business Concerns by Company Turnover (%), 2011–2012Table 35: Actions to Maintain and Secure Buyer Business – Buyer vs. Supplier Responses(%), 2011Table 36: Actions to Maintain and Secure Buyer Business – Buyer Responses (%), 2011Table 37: Actions to Maintain and Secure Buyer Business by Region (%), 2011Table 38: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2011Table 39: Actions to Maintain and Secure Buyer Business by Procurement Budget (%), 2011Table 40: Annual Procurement Budgets of Pharmaceutical Buyers in US$ (%), 2009–2011Table 41: Annual Procurement Budgets in US$ by Company Type (%), 2011Table 42: Annual Procurement Budgets in US$ by Region(%), 2011Table 43: Annual Procurement Budgets in US$ by Company Turnover (%), 2011Table 44: Change in Total Procurement Expenditure of Pharmaceutical Buyers (%), 2009–2011Table 45: Expected Change in Total Procurement Expenditure by Company Type (%), 2011Table 46: Expected Change in Total Procurement Expenditure by Region (%), 2011Table 47: Expected Change in Total Procurement Expenditure by Company Turnover (%),2011Table 48: Planned Change in Expenditure vs. Revenue Growth Optimism (%), 2011Table 49: Planned Change in Expenditure vs. Cost Containment (%), 2011Table 50: Company Revenue Growth Optimism: Cross Industry Comparison (%), 2011Table 51: Change in Expenditure by Products and Services by Pharmaceutical Manufacturer(%), 2011Table 52: Future Change in Expenditure by Product and Service Category by CRO and CMO(%), 2011Table 53: Variations in Regional Supplier Prices (%), 2011Table 54: Variations in Regional Supplier Prices by Company Type (%), 2011Table 55: Variations in Supplier Prices by Region (%), 2011Table 56: Variations in Regional Supplier Prices by Company Turnover (%), 2011Table 57: Critical Success Factors for Supplier Selection – Buyers vs. Suppliers, 2011Table 58: Critical Success Factors for Supplier Selection – All Pharmaceutical Buyers, 2011Table 59: Future Procurement Objectives (%), 2011Table 60: Future Procurement Objectives by Company Type (%), 2011Table 61: Future Procurement Objectives by Region (%), 2011Table 62: Future Procurement Objectives by Company Turnover (%), 2011Table 63: E–Procurement: Level of Implementation (%), 2011Table 64: E–Procurement: Level of Implementation by Company Type (%), 2011
  6. 6. Table 65: E–Procurement: Level of Implementation by Region (%), 2011Table 66: E–Procurement: Level of Implementation by Company Turnover (%), 2011Table 67: Survey Results – Closed QuestionsList of FiguresFigure 1: Revenue Growth Optimism (%), 2009–2011Figure 2: Revenue Growth Optimism by Company Type(%), 2009–2011Figure 3: Revenue Growth Optimism by Region (%), 2009–2011Figure 4: Revenue Growth Optimism by Turnover (%), 2011Figure 5: Revenue Growth Optimism by Senior Level Respondents (%), 2011Figure 6: Company Revenue Growth Optimism: Cross Industry Comparisons (%), 2011Figure 7: Key Changes In Business Structure in the Pharmaceutical Manufacturer Industry(%), 2011Figure 8: Key Changes In Business Structure in the CRO and CMO Industry (%), 2011Figure 9: Key Changes In Business Structure in the Drug Manufacturing Supplier Industry(%), 2011Figure 10: Merger and Acquisition Expectations Pharmaceutical Manufacturer Industry,2009–2011Figure 11: Merger and Acquisition Expectations CRO and CMO Industry, 2009–2011Figure 12: Merger and Acquisition Expectations Drug Manufacturing Supplier Industry,2009–2011Figure 13: Merger and Acquisition Expectations by Region, 2011Figure 14: Merger and Acquisition Expectations by Company Turnover, 2011Figure 15: Top Ten Growth Regions (%), 2011Figure 16: Top Five Emerging Markets, 2011Figure 17: Demand in Emerging Markets by Pharmaceutical Manufacturer (%), 2011Figure 18: Demand in Emerging Markets by CRO and CMO Industry (%), 2011Figure 19: Demand in Emerging Markets by Drug Manufacturing Supplier (%), 2011Figure 20: Demand in Emerging Markets by Region (%), 2011Figure 21: Demand in Emerging Markets by Company Turnover (%), 2011Figure 22: Top Five Developed Countries Targeted for Growth, 2011Figure 23: Growth Expectations in Developed Countries by Pharmaceutical Manufacturer(%), 2011Figure 24: Growth Expectations in Developed Countries by CRO and CMO (%), 2011Figure 25: Growth Expectations in Developed Countries by Drug Manufacturing Supplier(%), 2011Figure 26: Growth Expectations in Developed Countries by Region (% ‘Increase’Responses), 2011Figure 27: Growth Expectations in Developed Countries by Turnover (% ‘Increase’Responses), 2011Figure 28: Leading Business Concerns (%), 2011–2012Figure 29: Leading Business Concerns (%), 2011–2012Figure 30: Actions to Maintain and Secure Buyer Business – Buyer vs. Supplier Responses(%), 2011Figure 31: Actions to Maintain and Secure Buyer Business – Buyer Responses (%), 2011Figure 32: Actions to Maintain and Secure Buyer Business by Company Turnover (%), 2011Figure 33: Actions to Maintain and Secure Buyer Business by Purchasing Decision Authority(%), 2011
  7. 7. Figure 34: Annual Procurement Budgets of Pharmaceutical Buyers in US$ (%), 2009–2011Figure 35: Annual Procurement Budgets in US$ by Company Type (%), 2011Figure 36: Annual Procurement Budgets in US$ by Region(%), 2011Figure 37: Annual Procurement Budgets in US$ by Company Turnover (%), 2011Figure 38: Change in Total Procurement Expenditure of Pharmaceutical Buyers (%), 2009–2011Figure 39: Expected Change in Total Procurement Expenditure by Company Type (%), 2011Figure 40: Expected Change in Total Procurement Expenditure by Region (%), 2011Figure 41: Expected Change in Total Procurement Expenditure by Company Turnover (%),2011Figure 42: Change in Expenditure by Products and Services by Pharmaceutical Manufacturer(%), 2011Figure 43: Future Change in Expenditure by Product and Service Category by CRO and CMO(%), 2011Figure 44: Increase in Expenditure by Product and Service of Pharmaceutical Buyers byRegion (%), 2011Figure 45: Increase in Expenditure by Product and Service of Pharmaceutical Buyers byTurnover (%), 2011Figure 46: Variations in Regional Supplier Prices (%), 2011Figure 47: Variations in Regional Supplier Prices by Company Type (%), 2011Figure 48: Variations in Supplier Prices by Region (%), 2011Figure 49: Variations in Regional Supplier Prices by Company Turnover (%), 2011Figure 50: Critical Success Factors for Supplier Selection – Buyers vs. Suppliers, 2011Figure 51: Critical Success Factors for Supplier Selection – Buyers vs. Suppliers, 2011Figure 52: Critical Success Factors for Supplier Selection – All Pharmaceutical Buyers, 2011Figure 53: Future Procurement Objectives (%), 2011Figure 54: E–Procurement: Level of Implementation (%), 2011Figure 55: E–Procurement: Level of Implementation by Company Type (%), 2011Figure 56: E–Procurement: Level of Implementation by Region (%), 2011Figure 57: E–Procurement: Level of Implementation by Company Turnover (%), 2011Latest Market Research Reports:Africa LNG Market Outlook – New Opportunities, Trends and Drivers to 2020Monthly Global LNG Trade & Price Database, 2010Africa LNG Industry Outlook to 2020- Analysis of Trade pattern, pricing, supply-demand,capacity, competition, technology and terminalsGlobal Pharmaceutical Industry Outlook Survey 2011–2012: Industry Dynamics, MarketTrends and Opportunities, Buyer Spend and Procurement StrategiesArgentina Retail Report Q3 2011Egypt Water Report Q3 2011
  8. 8. About Us:ReportsnReports is an online library of over 75,000 market research reports and in-depthmarket research studies & analysis of over 5000 micro markets. We provide 24/7 online andoffline support to our customers. Get in touch with us for your needs of market researchreports.Follow us on Twitter: http://twitter.com/marketsreportsOur Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689Contact:Mr. Priyank7557 Rambler road,Suite 727, Dallas, TX 75231Tel: +1-888-989-8004 EXT 106E-mail: sales@reportsandreports.comhttp://www.reportsnreports.comBlog: http://www.reportsnreportsblog.com

×